Human parainfluenza virus 2 (hPIV2)
|
V protein
|
Protein degradation
|
Human, mouse
|
65
|
Parainfluenza virus 5 (hPIV5), previously Simian virus 5 (SV5)
|
V protein
|
STAT2 dependent STAT1 antagonism
|
Human, mouse STAT2 unaffected
|
41 and 67
|
Sendai virus (SeV)
|
C protein
|
Inhibit phosphorylation/activation by associating with STAT1
|
Rodent pathogen, Experiments on human cell lines
|
64
|
Hendra virus
|
V protein
|
Complex formation and cytoplasmic sequestration
|
Equine, Human
|
59
|
Nipah virus
|
V protein
|
Complex formation and cytoplasmic sequestration
|
Human
|
57 and 58
|
Measles virus
|
V protein
|
Complex formation and cytoplasmic sequestration, suppression of DC activation
|
Human
|
52 and 54
|
Respiratory syncytial virus (RSV)
|
NS1, NS2
|
Proteasomal degradation of complex
|
Human
|
61 and 63
|
Dengue virus (DENV)
|
NS5
|
Protein degradation, blocking phosphorylation
|
Human, mouse STAT2 unaffected
|
69–72
|
Japanese encephalitis virus (JEV)
|
unknown
|
Blocking tyrosine phosphorylation
|
Human, non-human primate
|
83
|
Langat virus
|
NS5
|
Blocking tyrosine phosphorylation
|
non-human primate
|
84
|
Herpes simplex virus 2 (HSV2)
|
unknown
|
mRNA and protein degradation, blocking phosphorylation
|
Human
|
50
|
Lymphocytic choriomeningitis virus (LCMV)
|
unknown
|
Suppression of DC development via STAT1 independent STAT2 dependent IFN signaling
|
Mouse
|
52
|
| Mouse cytomegalovirus (MCMV) |
M27 |
Downregulation of STAT2 protein |
Mouse |
51 |
